drugset / Trial / NCT04192331

Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer

NCT04192331 ↗

Phase 2 Unknown 97 enrolled Peking University Cancer Hospital & Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

What is the best dosage of Nab-Paclitaxel for chinese? This study would divide patients into two dosage groups: 1) 125mg/m2, 30 minutes intravenous injection, d1, 8, 21 days for a cycle(clinical use); 2) 125mg/m2 d1, 8, 15, 30 minutes intravenous injection, 28 days for a cycle(guideline recommand). Treatment to disease progression. The efficacy (CR, PR, SD, PD) is evaluated every 2-4 cycles.If the patient withdraws from the trial because he cannot tolerate the toxicity caused by one of the drugs, such as neurotoxicity or bone marrow toxicity, it is recommended to switch to other drugs and follow up to PFS and OS.Each group was planned to include 30 patients.

Timeline

Start
2019-02-21
Primary completion
2023-01-26
Completion
2023-01-26

Outcome

Met primary endpoint

paper mPFS) was observed in the 3-week versus the 4-week schedule in the overall population (not reached vs. 6.8 months; hazard ratio [HR] = 0.44; P = .029). PMID 37882706 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nab-paclitaxel Small molecule 125 mg/m2 Intravenous

Indications